MALVAC 2009: Progress and Challenges in Development of Whole Organism Malaria Vaccines for Endemic Countries, 3-4 June 2009, Dakar, Senegal

Vaccine

Volumn 28, Issue 30, 2010, Pages 4695-4702

  Pinder, M ^a   Moorthy, V S ^a,b,f   Akanmori, B D ^c   Genton, B ^d   Brown, G V ^e  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d WHO REGIONAL OFFICE FOR AFRICA   (Congo)

^e SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Clinical trial; Conference report; Malaria vaccine; P. falciparum

Indexed keywords

ATTENUATED SPOROZOITE VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; LIQUID NITROGEN; LIVE VACCINE; MALARIA VACCINE; ORAL POLIOMYELITIS VACCINE; PARASITIZED RED BLOOD CELL VACCINE; RABIES VACCINE; UNCLASSIFIED DRUG; WART VIRUS VACCINE; WHOLE ORGANISM MALARIA VACCINE;

AFRICA; BLOODSTREAM INFECTION; CONFERENCE PAPER; CRYOPRESERVATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MANUFACTURE; DRUG PURITY; DRUG QUALITY; DRUG RESEARCH; DRUG SCREENING; DRUG STABILITY; DRUG STORAGE; ENDEMIC DISEASE; ERYTHROCYTE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; MALARIA FALCIPARUM; NONHUMAN; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX MALARIA; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RESEARCH ETHICS; SPOROZOITE; UNSPECIFIED SIDE EFFECT; ANIMAL; IMMUNOLOGY; MALARIA; MEDICOLEGAL ASPECT; PLASMODIUM; RESEARCH; SENEGAL;

ANIMALS; DRUG STABILITY; DRUG STORAGE; HUMANS; LEGISLATION, MEDICAL; MALARIA; MALARIA VACCINES; PLASMODIUM; RESEARCH; SENEGAL; SPOROZOITES; VACCINES, ATTENUATED;

EID: 77954218872     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.091     Document Type: Conference Paper

References (13)

1. Malaria vaccine technology roadmap final report 2006, www.malariavaccineroadmap.net.
2. Bejon P., Lusingu J., Olutu A., et al. Efficacy of the RTS, S/AS01E vaccine against clinical episodes of falciparum malaria in 5 to 17 month old children in Kenya and Tanzania. N Engl J Med 2008, 359(24):2521-2532.
3. Moorthy V.S., Reed Z., Smith P.G. MALVAC 2008: measures of efficacy of malaria vaccines in phase 2b and phase 3 trials-scientific, regulatory and public health perspectives. Vaccine 2009, 27(January (5)):624-628.
4. Clyde D.F. Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75. Bull World Health Organ 1990, 68(Suppl.):9-12.
5. Hoffman S.L., Goh L.M., Luke T.C., Schneider I., Le T.P., Doolan D.L., et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002, 185(8):1155-1164.
6. Kennedy M.C., Wang J., Zhang Y., Miles A.P., Chitsaz F., Saul A., et al. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect Immun 2002, 70(December (12)):6948-6960.
7. Siddiqui W.A. An effective immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum. Science 1977, 197(July (4301)):388-389.
8. Cox F.E. Protective immunity between malaria parasites and piroplasms in mice. Bull World Health Organ 1970, 43(2):325-336.
9. Pombo D.J., Lawrence G., Hirunpetcharat C., Rzepczyk C., Bryden M., Cloonan N., et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 2002, 360(9333):610-617.
10. Cheng Q., Lawrence G., Reed C., Stowers A., Ranford-Cartwright L., Creasey A., et al. Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines. Am J Trop Med Hyg 1997, 57(4):495-500.
11. Lawrence G., Cheng Q.Q., Reed C., Taylor D., Stowers A., Cloonan N., et al. Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. Vaccine 2000, 18(18):1925-1931.
12. Sanderson F., Andrews L., Douglas A.D., Hunt-Cooke A., Bejon P., Hill A.V. Blood-stage challenge for malaria vaccine efficacy trials: a pilot study with discussion of safety and potential value. Am J Trop Med Hyg 2008, 78(June (6)):878-883.
13. WHO website on vaccine vial monitors (VVM). Available from: http://www.who.int/immunization_standards/vaccine_quality/vvm_10years_index/en/index.html.